Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Effects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD.

Epstein JN, Brinkman WB, Froehlich T, Langberg JM, Narad ME, Antonini TN, Shiels K, Simon JO, Altaye M.

Neuropsychopharmacology. 2011 Apr;36(5):1060-72. doi: 10.1038/npp.2010.243. Epub 2011 Jan 19.

2.

Mediators of methylphenidate effects on math performance in children with attention-deficit hyperactivity disorder.

Froehlich TE, Antonini TN, Brinkman WB, Langberg JM, Simon JO, Adams R, Fredstrom B, Narad ME, Kingery KM, Altaye M, Matheson H, Tamm L, Epstein JN.

J Dev Behav Pediatr. 2014 Feb-Mar;35(2):100-7. doi: 10.1097/DBP.0000000000000025.

3.

Stimulant treatment reduces lapses in attention among children with ADHD: the effects of methylphenidate on intra-individual response time distributions.

Spencer SV, Hawk LW Jr, Richards JB, Shiels K, Pelham WE Jr, Waxmonsky JG.

J Abnorm Child Psychol. 2009 Aug;37(6):805-16. doi: 10.1007/s10802-009-9316-2.

4.

Motivational incentives and methylphenidate enhance electrophysiological correlates of error monitoring in children with attention deficit/hyperactivity disorder.

Groom MJ, Liddle EB, Scerif G, Liddle PF, Batty MJ, Liotti M, Hollis CP.

J Child Psychol Psychiatry. 2013 Aug;54(8):836-45. doi: 10.1111/jcpp.12069. Epub 2013 May 13.

5.

Dissociation in response to methylphenidate on response variability in a group of medication naïve children with ADHD.

Johnson KA, Barry E, Bellgrove MA, Cox M, Kelly SP, Dáibhis A, Daly M, Keavey M, Watchorn A, Fitzgerald M, McNicholas F, Kirley A, Robertson IH, Gill M.

Neuropsychologia. 2008 Apr;46(5):1532-41. doi: 10.1016/j.neuropsychologia.2008.01.002. Epub 2008 Jan 12.

PMID:
18289615
6.
7.

Evidence for higher reaction time variability for children with ADHD on a range of cognitive tasks including reward and event rate manipulations.

Epstein JN, Langberg JM, Rosen PJ, Graham A, Narad ME, Antonini TN, Brinkman WB, Froehlich T, Simon JO, Altaye M.

Neuropsychology. 2011 Jul;25(4):427-441. doi: 10.1037/a0022155. Erratum in: Neuropsychology. 2013 Jan;27(1):106.

8.

Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.

Rubia K, Halari R, Cubillo A, Mohammad AM, Brammer M, Taylor E.

Neuropharmacology. 2009 Dec;57(7-8):640-52. doi: 10.1016/j.neuropharm.2009.08.013. Epub 2009 Aug 26.

PMID:
19715709
9.

The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder.

Coghill DR, Rhodes SM, Matthews K.

Biol Psychiatry. 2007 Nov 1;62(9):954-62. Epub 2007 Jun 1.

PMID:
17543895
10.

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ; COMACS Study Group.

Pediatrics. 2004 Mar;113(3 Pt 1):e206-16.

PMID:
14993578
11.

Effect of methylphenidate on motivation in children with attention-deficit/hyperactivity disorder.

Chelonis JJ, Johnson TA, Ferguson SA, Berry KJ, Kubacak B, Edwards MC, Paule MG.

Exp Clin Psychopharmacol. 2011 Apr;19(2):145-53. doi: 10.1037/a0022794.

PMID:
21463072
12.

Methylphenidate improves some but not all measures of attention, as measured by the TEA-Ch in medication-naïve children with ADHD.

Paton K, Hammond P, Barry E, Fitzgerald M, McNicholas F, Kirley A, Robertson IH, Bellgrove MA, Gill M, Johnson KA.

Child Neuropsychol. 2014;20(3):303-18. doi: 10.1080/09297049.2013.790358. Epub 2013 May 2.

PMID:
23639119
13.

Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication.

Bedard AC, Ickowicz A, Logan GD, Hogg-Johnson S, Schachar R, Tannock R.

J Abnorm Child Psychol. 2003 Jun;31(3):315-27.

PMID:
12774864
14.

Sex differences in attentional performance and their modulation by methylphenidate in children with attention-deficit/hyperactivity disorder.

Günther T, Herpertz-Dahlmann B, Konrad K.

J Child Adolesc Psychopharmacol. 2010 Jun;20(3):179-86. doi: 10.1089/cap.2009.0060.

PMID:
20578930
15.

Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD?

Boonstra AM, Kooij JJ, Oosterlaan J, Sergeant JA, Buitelaar JK.

J Clin Exp Neuropsychol. 2005 Apr;27(3):278-98.

PMID:
15969353
16.

OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.

Bron TI, Bijlenga D, Boonstra AM, Breuk M, Pardoen WF, Beekman AT, Kooij JJ.

Eur Neuropsychopharmacol. 2014 Apr;24(4):519-28. doi: 10.1016/j.euroneuro.2014.01.007. Epub 2014 Jan 18.

PMID:
24508533
17.

Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.

Kim BN, Kim JW, Cummins TD, Bellgrove MA, Hawi Z, Hong SB, Yang YH, Kim HJ, Shin MS, Cho SC, Kim JH, Son JW, Shin YM, Chung US, Han DH.

J Clin Psychopharmacol. 2013 Jun;33(3):356-62. doi: 10.1097/JCP.0b013e31828f9fc3.

PMID:
23609393
18.

Methylphenidate, interstimulus interval, and reaction time performance of children with attention deficit/hyperactivity disorder: a pilot study.

van der Meere JJ, Shalev RS, Borger N, Wiersema JR.

Child Neuropsychol. 2009 Nov;15(6):554-66. doi: 10.1080/09297040902758803.

PMID:
19296298
19.

Predicting methylphenidate response in attention deficit hyperactivity disorder: a preliminary study.

Johnston BA, Coghill D, Matthews K, Steele JD.

J Psychopharmacol. 2015 Jan;29(1):24-30. doi: 10.1177/0269881114548438. Epub 2014 Sep 18.

PMID:
25237119
20.

Reinforcement and Stimulant Medication Ameliorate Deficient Response Inhibition in Children with Attention-Deficit/Hyperactivity Disorder.

Rosch KS, Fosco WD, Pelham WE Jr, Waxmonsky JG, Bubnik MG, Hawk LW Jr.

J Abnorm Child Psychol. 2016 Feb;44(2):309-21. doi: 10.1007/s10802-015-0031-x.

Supplemental Content

Support Center